Loading...
XSTO
SEDANA
Market cap106mUSD
Dec 05, Last price  
10.02SEK
1D
0.60%
1Q
-26.11%
IPO
70.55%
Name

Sedana Medical AB (publ)

Chart & Performance

D1W1MN
XSTO:SEDANA chart
P/E
P/S
5.57
EPS
Div Yield, %
Shrs. gr., 5y
3.46%
Rev. gr., 5y
20.06%
Revenues
179m
+16.17%
28,113,00032,155,00040,427,70057,896,20071,645,600141,770,000159,152,000122,865,000153,867,000178,754,000
Net income
-11m
L-82.09%
-1,205,0001,286,000-3,875,700-6,869,100-16,357,700-27,139,000-57,966,000-73,507,000-59,612,000-10,674,000
CFO
-12m
L-69.08%
0238,000495,600-5,778,900-8,700,200-7,846,000-41,221,000-115,433,000-38,061,000-11,769,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-, which are disposable medical devices that enables the administration of volatile anesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and FlurAbsorb mount to hold the filter during scavenging of anesthetic gas. It also provides AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and various accessories comprising DRYLINE II Water Traps, WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Line. Sedana Medical AB (publ) was founded in 1999 and is headquartered in Danderyd, Sweden.
IPO date
Jun 21, 2017
Employees
84
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT